Showing 1–24 of 68 results

Abevmy 400 mg Injection

Molecule : BevacizumabManufacturer : Mylan

Alkacel 2 mg Tablet

Molecule : MelphalanManufacturer : Celon Lab

Alkacel 5 mg Tablet

Molecule : MelphalanManufacturer : Celon Lab

Alpesib 150 mg Tablet

Molecule : AlpelisibManufacturer : Everest Pharma

Aromasin 25 mg Tablet

Molecule : ExemestaneManufacturer : Pfizer

Bevatas 400 mg Injection

Molecule : BevacizumabManufacturer : Intas Pharma

Cacit 500 mg Tablet

Molecule : CapecitabineManufacturer : Zydus

Capegard 500 mg Tablet

Molecule : CapecitabineManufacturer : Cipla

Capivast 200 mg Tablet

Molecule : CapivasertibManufacturer : Everest Pharma

Capixet 500 mg Tablet

Molecule : CapecitabineManufacturer : Everest Pharma

Combinib 250 mg Tablet

Molecule : LapatinibManufacturer : Cipla

Cycloxan 50 mg Tablet

Molecule : CyclophosphamideManufacturer : Zydus

Cytogem 200 mg Injection

Molecule : GemcitabineManufacturer : Dr Reddys Laboratories Ltd

Daxotel 120 mg Injection

Molecule : DocetaxelManufacturer : Fresenius Kabi

Enhertu 100 mg Injection

Molecule : Trastuzumab DeruxtecanManufacturer : Astrazeneca

Evermil 10 mg Tablet

Molecule : EverolimusManufacturer : Glenmark

Evermil 5 mg Tablet

Molecule : EverolimusManufacturer : Glenmark

Femara 2.5 mg Tablet

Molecule : LetrozoleManufacturer : Novartis

Femistra 1 mg Tablet

Molecule : AnastrozoleManufacturer : Zydus

Fempro 2.5 mg Tablet

Molecule : LetrozoleManufacturer : Cipla

Fulvenat 250 mg Injection

Molecule : FulvestrantManufacturer : Natco Pharma

Herceptin 150 mg Vial

Molecule : TrastuzumabManufacturer : Roche

Herduo 250 mg Tablet

Molecule : LapatinibManufacturer : Natco Pharma

Hernix 40 mg Tablet

Molecule : NeratinibManufacturer : Beacon Pharma

Related Posts:

FDA Approves Vepdegestrant for ER+/HER2–, ESR1-Mutated Breast Cancer: A New Targeted Option

Medical Review: This article was reviewed by Dr. Sophie Reynolds on May 6, 2026. Breast cancer treatment continues to evolve

READ MORE »
First-Line Palbociclib Combination Boosts PFS in HR+/HER2+ mBC – PATINA Findings

n Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 1, 2026.n n Metastatic breast cancer (mBC)

READ MORE »
Atirmociclib and Fulvestrant Together Delay Cancer Progression in HR+/HER2– Cases

Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 23, 2026. Advancements in breast cancer treatment continue

READ MORE »